Skip to main content
. 2015 Aug 7;81(17):5694–5702. doi: 10.1128/AEM.01150-15

TABLE 2.

NAT assays included in feasibility study

NAT assay use and amplification/detection method Extraction method Assay no.
NAT assays used for (semi)quantitative evaluation
    In-house RT-PCR A QIAamp viral RNA minikit
    In-house RT-PCR B DNeasy blood and tissue kit
    In-house RT-PCR C QiaSymphony
    In-house RT-PCR D Phenol-chloroform
    Intego Mycoplasma InviMag universal kit/IG 4
    Intego Mycoplasma Chemagen RSMI 11
    Intego Mycoplasma QIAamp DNA blood minikit 15
    Microsart AMP Mycoplasma InviMag universal kit/IG 3
    MycoSEQ Mycoplasma real-time PCR PrepSEQ sample preparation kit 5, 8, 9, 10
    MycoSEQ Mycoplasma real-time PCR NucliSENS easyMAG 7
    MycoTool Mycoplasma real-time PCR MagNA Pure 1
    PLEX-ID Mycoplasma detection assay Bead-beating lysis 2
    Venor GeM qEP QIAamp DNA blood minikit 15
NAT assays used for qualitative evaluation
    CytoInspect PCR/microarray CytoInspect DNA extraction kit 18, 21, 24
    In-house nested PCR E QIAamp DNA minikit
    In-house RT-PCR F Phenol-chloroform
    In-house RT-PCR G Silica columns
    MilliPROBE Target capture (rRNA) 26
    MycoTool Mycoplasma Manual, 2-propanol 19
    Venor GeM Advance MB DNA extraction kit 20
    Venor GeM Advance QIAamp DNA blood minikit 25